Inside This Issue of JACC  by unknown
I
Snside This Issue of JACC
EPTEMBER 11, 2007, VOLUME 50, NO. 11Clinical Trial
Hemodialysis Prevents Contrast-Induced Nephropathy
Researchers in Taiwan performed a study to determine whether prophylactichemodialysis after coronary angiography would prevent contrast-induced ne-
phropathy. Eighty-two patients with chronic renal failure (creatinine 3.5 mg/dl)
undergoing angiography were randomly assigned to receive either normal saline
intravenously and postprocedure hemodialysis or fluid supplement only. Hemodialy-
sis, started approximately 1 hour after angiography, reduced the need for both tempo-
rary and permanent dialysis by substantial proportions. Based on these results, prophy-
lactic hemodialysis immediately after angiography is an effective and safe strategy to
improve renal outcome in patients with advanced renal failure. See page 1015.
Coronary Artery Disease
ST-Segment Depression is More Sensitive Than
ST-Segment Elevation for the Diagnosis of Infarction
Martin and colleagues compared presentation electrocardiograms with cardiacbiomarker levels and delayed enhancement on cardiac magnetic resonance
imaging to determine the significance of ST-segment depression.Using current Amer-
icanCollege ofCardiology/European Society ofCardiology guidelines for ST-segment
elevation myocardial infarction, the sensitivity was 50% and specificity 97% for acute
myocardial infarction (AMI). Consideration of ST-segment depression in addition to
elevation increased sensitivity for detection of AMI to 84%, with similar specificity.
There were no significant differences in infarction size between patients meeting
criteria for ST-segment elevation criteria and those with ST-segment depression. In
patients admitted to the hospital with possible AMI, the consideration of both ST-
segment elevation anddepression significantly increases the sensitivity for the detection
of AMI without significantly decreasing the specificity. See page 1021.
Page 1057
Heart Failure
New Biomarker for CHF Severity: GDF-15
Growth differentiation factor (GDF)-15 is a stress-responsive member of thetransforming growth factor- cytokine superfamily that has recently been ob-
served to be increased in patients with chronic heart failure (CHF). Kempf and
colleaguesmeasuredGDF-15 levels in 455 patients withCHF (median left ventricular
ejection fraction of 32%) who were then followed for 4 years. Seventy-five percent of
the patients had GDF-15 levels 1,200 ng/l, the upper limit of normal in healthy
individuals. GDF-15 levels were closely related to New York Heart Association
functional class, amino-terminal pro–B-type natriuretic peptide, and the risk of death.
GDF-15 is a new biomarker of the risk of death in patients with CHF, providing
prognostic information beyond established clinical and biochemical markers.
See page 1054. See figure.
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Peripheral Arterial Disease
Low Testosterone, High Estradiol Predict PAD in Men
The influence of sex hormones on thrombotic and atherogenic risk remains poorlyunderstood. TheMrOS study has enrolled 3,000 Swedishmen aged between 69
and 80 years. Peripheral arterial disease (PAD) was defined as an ankle-brachial index
0.90. Low serum levels of free testosterone and high levels of free estradiol were
associated with increased likelihood of PAD. This study suggests that high levels of
endogenous testosterone and low levels of estradiol may be protective against PAD.
See page 1070. See figure.
Page 1084
Cardiac Imaging
Limited Utility of SPECT for Routine Screening in Patients With AF
Although noninvasive stress testing is recommended by the American College ofCardiology Foundation/American Society of Nuclear Cardiology appropriate-
ness criteria in selected asymptomatic patients with atrial fibrillation (AF), its prognos-
tic utility has not been demonstrated. Askew and colleagues compared single-photon
emission computed tomography (SPECT) study results and 5-year mortality in pa-
tients without symptoms of chest pain or dyspnea who were in AF at the time of their
study with a control group in normal sinus rhythm. The mean summed stress score
(SSS) and the proportion of patients with high-risk studies were similar. The SSS
predicted mortality in both groups, but mortality was significantly higher in AF
patients. This suggests that SPECT screening for asymptomatic patients with AF
provides prognostic information, although the high rate of low-risk studies suggests
that not every patient should be screened. See page 1080. See figure.
